Invivyd Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
/ 
Frequently asked questions
To buy Invivyd Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Invivyd Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Invivyd Inc. is IVVD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Invivyd Inc. has its primary listing on NASDAQ. You can trade Invivyd Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Invivyd Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Invivyd Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Invivyd Inc. or others.